1st Congress on Fatty Liver and Metabolic Syndrome 

will be held on 12-14 November, 2009, Budapest, Hungary Ramada Resort Hotel.
 
All of us are aware of the fast growing attention of liver and metabolism related issues. Fatty Liver and Metabolic Diseases focuses on the latest advances in all biomedical aspects and therapeutic modalities of hepatic steatosis, steatohepatitis, progression of fibrosis in the liver, concommitant hepatitis B or C virus infection, hepatocellular carcinoma and will discuss them with a select group of scientists in the field from all over the world (see www.fattyliver.hu for details).
 

• Giuseppe Poli (Turin, Italy): Lipid oxidation, inflammation and fibrosis
• Lajos Szollár (Budapest, Hungary): The metabolic syndrome
• Neven Zarkovic (Zagreb, Croatia): The relevance of lipid peroxidation in liver pathopysiology
• Thomas Baumert (Strasbourg, France): Hepatitis C virus infection and lipid metabolism
• László Halmy (Budapest, Hungary): Obesity and fatty liver
• Chrys Chatgilialoglu (Bologna, Italy): Trans fatty acids in membranes: from nutrition to radical stress
• Fiorella Biasi (Turin, Italy): Lipid oxidation and fibrogenesis in cancer progression
• Peter Fülöp (Debrecen, Hungary): Molecular biology of lipid accumulation in the liver
• Zsuzsa Schaff (Budapest, Hungary): Pathologic significance of the fat in the liver cells
• Grzegorz Bartosz (Lodz, Poland): Reactive oxygen species: Destroyers or messengers in non-alcoholic fatty liver?
• Gabriella Lengyel (Budapest, Hungary): Fatty liver and respond to combined peginterferon and ribavirin treatment
• György Paragh (Debrecen, Hungary): The effect of statins on the hepatocyte function
• Tatjana Ábel (Budapest, Hungary): Statins in the therapy of fatty liver
• János Fehér (Budapest, Hungary): Therapy modalities in non-alcoholic steatohepatitis